Finance

Lists
Why is SVRA down 2,23%?
Dive Deeper
SVRA:NASDAQ
Savara Inc
5,04 $
-2,23%
(-0,11) 1D
5,04 $
0,00% (0,00)
After hours
Closed: 1 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SVRA...
Open
5,15 $
High
5,24 $
Low
5,03 $
Mkt. cap
1,04 млрд
Avg. vol.
1,88 млн
Volume
0,00
52-wk high
7,00 $
52-wk low
3,34 $
EPS
-0,58 $
Beta
0,26
Shares outstanding
205,46 млн
No. of employees
70
Open
5,15 $
High
5,24 $
Low
5,03 $
Mkt. cap
1,04 млрд
Avg. vol.
1,88 млн
Volume
0,00
52-wk high
7,00 $
52-wk low
3,34 $
EPS
-0,58 $
Beta
0,26
Shares outstanding
205,46 млн
No. of employees
70
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
12 сағат бұрын
Savara stock sits 26.39 percent below its 52-week high
About Savara Inc
CEO-
Employees70
Founded1995
Headquarters-
Sector-
Websitesavarapharma.com
Analyst ratings
Based on 5 analysts giving stock ratings to SVRA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for SVRA in the last 3 months.
Highest
Current 5,04 $
16,00 $ (+217,15%)
Average
11,20 $ (+122,00%)
Lowest
9,00 $ (+78,39%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
16,00 $
+217,1%
08/26/2026
Vamil Divan
Guggenheim
Buy
Reiterated
11,00 $
+118%
08/20/2026
Francois Brisebois
LifeSci Capital
Buy
Reiterated
10,00 $
+98,2%
08/12/2026
Benjamin Burnett
Wells Fargo
Buy
Reiterated
9,00 $
+78,4%
08/11/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
10,00 $
+98,2%
08/12/2026
Andreas Argyrides
Chardan Capital
Buy
Maintained
11,00 $
+118%
06/03/2026
Last report
2026 ж. 11 там.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,16 $ / -0,15 $
-9,59%miss
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
20,59 млн
20,90 млн
-
21,95 млн
Cost of revenue
20,59 млн
20,90 млн
-
21,95 млн
Research and development expenses
-
-
23,40 млн
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,63 млн
12,53 млн
15,57 млн
18,99 млн
Operating expense
9,66 млн
12,52 млн
38,14 млн
19,01 млн
Total operating expenses
30,26 млн
33,42 млн
38,14 млн
40,96 млн
Operating income
-30,26 млн
-33,42 млн
-38,14 млн
-40,96 млн
Other non operating income
-
-
12,00 мың
-11,00 мың
EBT including unusual items
-29,56 млн
-32,24 млн
-37,28 млн
-40,23 млн
EBT excluding unusual items
-29,56 млн
-32,24 млн
-37,28 млн
-40,23 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-853,00 м.
-
Net income
-29,56 млн
-32,24 млн
-37,28 млн
-40,23 млн
Net profit margin
-
-
-
-
Earnings per share
-0,14
-0,13
-0,15
-0,16
Interest and investment income
548,00 м.
1,20 млн
1,06 млн
829,00 м.
Interest expense
-
-
-
-
Net interest expenses
548,00 м.
1,20 млн
1,06 млн
829,00 м.
Depreciation and amortization charges
36,00 мың
-11,00 мың
24,00 мың
28,00 мың
EBITDA
-30,22 млн
-33,40 млн
-38,11 млн
-40,94 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары